Pituitary adenylate cyclase–activating polypeptide (PACAP), an ancient molecule highly preserved across species, has been classified as a member of the secretin/glucagon/vasoactive intestinal peptide/growth hormone-releasing hormone polypeptide family. PACAP was first identified as a hypothalamic-releasing factor; nevertheless, it has subsequently been determined to have widespread distribution and function, including expression in the pituitary, gonads, placenta, central and peripheral nervous systems, intestinal tract, and adrenal gland. Consistent with its widespread distribution, PACAP has been found to exert pleiotropic effects. Although first described over 20 years ago, only relatively recently has substantial attention turned to evaluating PACAP’s role in the reproductive system. This review will focus on our current understanding of the expression pattern and function of PACAP in the hypothalamic–pituitary–gonadal axis.
MiyataAArimuraADahlRRIsolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun.1989;164(1):567–574.
2.
RawlingsSRHezarehM. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr Rev. 1996;17(1):4–29.
3.
ArimuraA. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol. 1998;48(5):301–331.
4.
SherwoodNMKruecklSLMcRoryJE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev. 2000;21(6):619–670.
5.
MiyataAJiangLDahlRDIsolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun. 1990;170(2):643–648.
6.
ArimuraAShiodaS. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol. 1995;16(1):53–88.
7.
VaudryDGonzalezBJBasilleMYonLFournierAVaudryH. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52(2):269–324.
8.
ArimuraASomogyvari-VighAMiyataAMizunoKCoyDHKitadaC. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 1991;129(5):2787–2789.
9.
HosoyaMKimuraCOgiKStructure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta. 1992;1129(2):199–206.
10.
OkazakiKKimuraCKosakaTExpression of human pituitary adenylate cyclase activating polypeptide (PACAP) cDNA in CHO cells and characterization of the products. FEBS Lett. 1992;298(1):49–56.
11.
KovesKGorcsTJKauszMArimuraA. Present status of knowledge about the distribution and colocalization of PACAP in the forebrain. Acta Biol Hung. 1994;45(2-4):297–321.
12.
ZhengMStreckRDScottRESeidahNGPintarJE. The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J Neurosci. 1994;14(8):4656–4673.
13.
DongWSeidelBMarcinkiewiczMChretienMSeidahNGDayR. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci. 1997;17(2):563–575.
14.
LiMNakayamaKShutoYSomogyvari-VighAArimuraA. Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase-activating polypeptide (PACAP). Peptides. 1998;19(2):259–268.
15.
KimuraCOhkuboSOgiKA novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun. 1990;166(1):81–89.
16.
BrubelRReglodiDJamborEInvestigation of pituitary of adenylate cyclase activating polypeptide in human gynecologic and other biologic fluids by using MALDI TOF mass spectrometry. J Mass Spectrom. 2011;46(2):189–194.
17.
HarmarAJArimuraAGozesIInternational Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev. 1998;50(2):265–270.
18.
ShiversBDGorcsTJGottschallPEArimuraA. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology. 1991;128(6):3055–3065.
19.
CauvinABuscailLGourletPThe novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides. 1990;11(4):773–777.
20.
CiccarelliESvobodaMDe NeefPPharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells. Eur J Pharmacol. 1995;288(3):259–267.
21.
SpenglerDWaeberCPantaloniCDifferential signal transduction by five splice variants of the PACAP receptor. Nature. 1993;365(6442):170–175.
22.
JournotLWaeberCPantaloniCDifferential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans. 1995;23(1):133–137.
23.
PisegnaJRWankSA. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem. 1996;271(29):17267–17274.
24.
PantaloniCBrabetPBilangesBAlternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem. 1996;271(36):22146–22151.
MooreJP Jr, BurgerLLDalkinACWintersSJ. Pituitary adenylate cyclase activating polypeptide messenger RNA in the paraventricular nucleus and anterior pituitary during the rat estrous cycle. Biol Reprod. 2005;73(3):491–499.
27.
NemethJTamasAJozsaRChanges in PACAP levels in the central nervous system after ovariectomy and castration. Ann N Y Acad Sci. 2006;1070:468–473.
28.
ParkJIKimWJWangLInvolvement of progesterone in gonadotrophin-induced pituitary adenylate cyclase-activating polypeptide gene expression in pre-ovulatory follicles of rat ovary. Mol Hum Reprod. 2000;6(3):238–245.
29.
KoCPark-SargeOK. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells. Biochem Biophys Res Commun. 2000;277(1):270–279.
30.
GraferCMThomasRLambrakosLMontoyaIWhiteSHalvorsonLM. GnRH stimulates expression of PACAP in the pituitary gonadotropes via both the PKA and PKC signaling systems. Mol Endocrinol. 2009;23(7):1022–1032.
31.
PurwanaINKanasakiHOrideAGnRH-induced PACAP and PAC1 receptor expression in pituitary gonadotrophs: a possible role in the regulation of gonadotropin subunit gene expression. Peptides. 2010;31(9):1748–1755.
LeeJParkHJChoiHSGonadotropin stimulation of pituitary adenylate cyclase-activating polypeptide (PACAP) messenger ribonucleic acid in the rat ovary and the role of PACAP as a follicle survival factor. Endocrinology. 1999;140(2):818–826.
34.
ParkHJLeeJWangLStage-specific expression of pituitary adenylate cyclase-activating polypeptide type I receptor messenger ribonucleic acid during ovarian follicle development in the rat. Endocrinology. 2000;141(2):702–709.
35.
GrasSHannibalJGeorgBFahrenkrugJ. Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. Endocrinology. 1996;137(11):4779–4785.
36.
KotaniEUsukiSKuboT. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on progestin biosynthesis in cultured granulosa cells from rat ovary and expression of mRNA encoding PACAP type IA receptor. J Reprod Fertil. 1998;112(1):107–114.
37.
ZhongYKassonBG. Pituitary adenylate cyclase-activating polypeptide stimulates steroidogenesis and adenosine 3′,5′-monophosphate accumulation in cultured rat granulosa cells. Endocrinology. 1994;135(1):207–213.
38.
BarberiMMuciacciaBMorelliMBStefaniniMCecconiSCanipariR. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Reproduction. 2007;134(2):281–292.
39.
KohPOKwakSDKangSSExpression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary. Mol Reprod Dev. 2000;55(4):379–386.
40.
MorelliMBBarberiMGambardellaACharacterization, expression, and functional activity of pituitary adenylate cyclase-activating polypeptide and its receptors in human granulosa-luteal cells. J Clin Endocrinol Metab. 2008;93(12):4924–4932.
41.
ParkJYParkJHParkHJStage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells. Endocrinology. 2001;142(9):3828–3835.
42.
ShutoYSomogyvari-VighAShiodaSOndaHArimuraA. Effect of hypophysectomy on pituitary adenylate cyclase-activating polypeptide gene expression in the rat testis. Peptides. 1995;16(6):1039–1044.
43.
KovesKArimuraAGorcsTGSomogyvari-VighA. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology. 1991;54(2):159–169.
44.
KivipeltoLAbsoodAArimuraASundlerFHakansonRPanulaP. The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain. J Chem Neuroanat. 1992;5(1):85–94.
45.
AndoENokiharaKNaruseS. Development of pituitary adenylate cyclase activating polypeptides (PACAPs) specific radioimmunoassay systems and distribution of PACAP-like immunoreactivity in guinea pig tissues. Biomed Pept Proteins Nucleic Acids. 1994;1(1):45–50.
46.
KimuraSOhshigeYLinLLocalization of pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamus-pituitary system in rats: light and electron microscopic immunocytochemical studies. J Neuroendocrinol. 1994;6(5):503–507.
47.
HannibalJMikkelsenJDFahrenkrugJLarsenPJ. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. Endocrinology. 1995;136(9):4116–4124.
48.
PigginsHDStampJABurnsJRusakBSembaK. Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat. J Comp Neurol. 1996;376(2):278–294.
49.
HannibalJMikkelsenJDClausenHHolstJJWulffBSFahrenkrugJ. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept. 1995;55(2):133–148.
50.
MuraseTKondoKArimaHThe expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: possible role of endogenous PACAP in vasopressin release. Neurosci Lett. 1995;185(2):103–106.
51.
KovesKArimuraASomogyvari-VighAVighSMillerJ.Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus. Endocrinology. 1990;127(1):264–271.
52.
TamadaYTanakaMIchitaniYOkamuraHYanaiharaNIbataY. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactive neuronal elements in rat hypothalamus and median eminence with special reference to morphological background of its effect on anterior pituitary—light and electron microscopic immunocytochemistry. Neurosci Lett. 1994;180(2):105–108.
53.
MikkelsenJDHannibalJFahrenkrugJLarsenPJOlceseJMcArdleC.Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary. J Neuroendocrinol. 1995;7(1):47–55.
54.
GottschallPETatsunoIMiyataAArimuraA. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology. 1990;127(1):272–277.
55.
OlceseJMcArdleCAMiddendorffRGreenlandK. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons. J Neuroendocrinol. 1997;9(12):937–943.
56.
LiSGrinevichVFournierAPelletierG. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain. Brain Res Mol Brain Res. 1996;41(1-2):157–162.
57.
SawangjaroenKCurlewisJD. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe. J Neuroendocrinol. 1994;6(5):549–555.
58.
BanksWAUchidaDArimuraASomogyvari-VighAShiodaS. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann N Y Acad Sci. 1996;805:270–277.
59.
BanksWAKastinAJKomakiGArimuraA. Passage of pituitary adenylate cyclase activating polypeptide 1-27 and pituitary adenylate cyclase activating polypeptide 1-38 across the blood-brain barrier. J Pharmacol Exp Ther. 1993;267(2):690–696.
60.
DowRCBennieJFinkG. Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat. J Endocrinol. 1994;142(1):R1–R4.
61.
OsugaYMitsuhashiNMizunoM.In vivo effect of pituitary adenylate cyclase activating polypeptide 38 (PACAP 38) on the secretion of luteinizing hormone (LH) in male rats. Endocrinol Jpn. 1992;39(1):153–156.
62.
AndersonSTSawangjaroenKCurlewisJD. Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion. Endocrinology. 1996;137(8):3424–3429.
63.
KantorOMolnarJHeinzelmannAFurstZArimuraAKovesK. The inhibitory effect of PACAP38 on ovulation is mediated by CRF and endogenous opioids. Ann N Y Acad Sci. 2000;921:405–409.
64.
KantorOMolnarJHeinzlmannAArimuraAFurstZKovesK. Study on the hypothalamic factors mediating the inhibitory effect of PACAP38 on ovulation. Peptides. 2001;22(12):2163–2168.
65.
KovesKKantorOMolnarJThe role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels. J Mol Neurosci. 2003;20(2):141–152.
66.
KovesKMolnarJKantorORole of PACAP in the regulation of gonadotroph hormone secretion during ontogenesis: a single neonatal injection of PACAP delays puberty and its intracerebroventricular administration before the critical period of proestrous stage blocks ovulation in adulthood. Ann N Y Acad Sci. 1998;865:590–594.
67.
ApostolakisEMLanzRO'MalleyBW. Pituitary adenylate cyclase-activating peptide: a pivotal modulator of steroid-induced reproductive behavior in female rodents. Mol Endocrinol. 2004;18(1):173–183.
68.
ArimuraA. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept. 1992;37(3):287–303.
69.
ArimuraA. Receptors for pituitary adenylate cyclase-activating polypeptide: comparison with vasoactive intestinal peptide receptors. Trends Endocrinol Metab. 1992;3(8):288–294.
70.
VighSArimuraAKovesKSomogyvari-VighASittonJFerminCD.Immunohistochemical localization of the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), in human and primate hypothalamus. Peptides. 1991;12(2):313–318.
71.
SudaKSmithDMGhateiMAMurphyJKBloomSR. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking. J Clin Endocrinol Metab. 1991;72(5):958–964.
72.
VighSArimuraAGottschallPEKitadaCSomogyvari-VighAChildsGV. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands. Peptides. 1993;14(1):59–65.
73.
HezarehMSchlegelWRawlingsSR. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta. J Neuroendocrinol. 1996;8(5):367–374.
74.
RawlingsSRPiuzISchlegelWBockaertJJournotL. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology. 1995;136(5):2088–2098.
75.
Bresson-BepoldinLJacquotMCSchlegelWRawlingsSR. Multiple splice variants of the pituitary adenylate cyclase-activating polypeptide type 1 receptor detected by RT-PCR in single rat pituitary cells. J Mol Endocrinol. 1998;21(2):109–120.
76.
MorrowJALutzEMWestKMFinkGHarmarAJ. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett. 1993;329(1-2):99–105.
77.
Radleff-SchlimmeALeonhardtSWuttkeWJarryH. Evidence for PACAP to be an autocrine factor on gonadotrope cells. Ann N Y Acad Sci. 1998;865:486–491.
78.
RobberechtPVertongenPVelkeniersBReceptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas. J Clin Endocrinol Metab. 1993;77(5):1235–1239.
79.
CannyBJRawlingsSRLeongDA. Pituitary adenylate cyclase-activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatotropes. Endocrinology. 1992;130(1):211–215.
80.
KovesKKantorOScammellJGArimuraA. PACAP colocalizes with luteinizing and follicle-stimulating hormone immunoreactivities in the anterior lobe of the pituitary gland. Peptides. 1998;19(6):1069–1072.
81.
SzaboENemeskeriAHeinzlmannASuzukiNArimuraAKovesK. Cell immunoblot assay study demonstrating the release of PACAP from individual anterior pituitary cells of rats and the effect of PACAP on LH release. Regul Pept. 2002;109(1-3):75–81.
82.
TsujiiTIshizakaKWintersSJ. Effects of pituitary adenylate cyclase-activating polypeptide on gonadotropin secretion and subunit messenger ribonucleic acids in perifused rat pituitary cells. Endocrinology. 1994;135(3):826–833.
83.
WintersSJTsujiiTAttardiB. Effects of GnRH and PACAP on gonadotropin secretion and subunit messenger RNAs. Ann N Y Acad Sci. 1996;805:343–352.
84.
TsujiiTWintersSJ. Effects of pulsatile pituitary adenylate cyclase activating polypeptide (PACAP) on gonadotropin secretion and subunit mRNA levels in perifused rat pituitary cells. Life Sci. 1995;56(13):1103–1111.
85.
RawlingsSRCannyBJLeongDA. Pituitary adenylate cyclase-activating polypeptide regulates cytosolic Ca2+ in rat gonadotropes and somatotropes through different intracellular mechanisms. Endocrinology. 1993;132(4):1447–1452.
86.
RawlingsSRDemaurexNSchlegelW. Pituitary adenylate cyclase-activating polypeptide increases [Ca2]i in rat gonadotrophs through an inositol trisphosphate-dependent mechanism. J Biol Chem. 1994;269(8):5680–5686.
87.
PerrinDSolingHDWuttkeWJarryH. The stimulatory effect of pituitary adenylate cyclase activating polypeptide (PACAP) on LH release from rat pituitary cells in vitro does not involve calcium mobilization. Exp Clin Endocrinol. 1993;101(5):290–296.
88.
HartGRGowingHBurrinJM. Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats. J Endocrinol. 1992;134(1):33–41.
89.
SchomerusEPochABuntingRMasonWTMcArdleCA. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line. Endocrinology. 1994;134(1):315–323.
90.
IshizakaKTsujiiTWintersSJ. Evidence for a role for the cyclic adenosine 3′,5′-monophosphate/protein kinase-A pathway in regulation of the gonadotropin subunit messenger ribonucleic acids. Endocrinology. 1993;133(5):2040–2048.
91.
KovesKMolnarJKantorOPACAP participates in the regulation of the hormonal events preceeding the ovulation. Acta Biol Hung. 1996;47(1-4):239–249.
92.
HammondPJTalbotKChapmanRGhateiMABloomSR. Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man. J Endocrinol. 1993;137(3):529–532.
93.
CullerMDPaschallCS. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone. Endocrinology. 1991;129(4):2260–2262.
94.
TurgeonJLKimuraYWaringDWMellonPL. Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Mol Endocrinol. 1996;10(4):439–450.
95.
BrannonKMMillion PasseCMWhiteCRBadeNAKingMWQuirkCC. Expression of the high mobility group A family member p8 is essential to maintaining tumorigenic potential by promoting cell cycle dysregulation in LbetaT2 cells. Cancer Lett. 2007;254(1):146–155.
96.
PincasHLaverriereJNCounisR. Pituitary adenylate cyclase-activating polypeptide and cyclic adenosine 3′,5′-monophosphate stimulate the promoter activity of the rat gonadotropin-releasing hormone receptor gene via a bipartite response element in gonadotrope-derived cells. J Biol Chem. 2001;276(26):23562–23571.
97.
KanasakiHPurwanaINMijiddorjTOrideAMiyazakiK. Possible involvement of PACAP and PACAP type 1 receptor in GnRH-induced FSH beta-subunit gene expression. Regul Pept. 2011;167(2-3):227–232.
98.
FowkesRCSidhuKKSosabowskiJKKingPBurrinJM. Absence of pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein alpha-subunit gene in LbetaT2 gonadotrophs reveals disrupted cAMP-mediated gene transcription. J Mol Endocrinol. 2003;31(2):263–278.
99.
FujiiYOkadaYMooreJPJrDalkinACWintersSJ. Evidence that PACAP and GnRH down-regulate follicle-stimulating hormone-beta mRNA levels by stimulating follistatin gene expression: effects on folliculostellate cells, gonadotrophs and LbetaT2 gonadotroph cells. Mol Cell Endocrinol. 2002;192(1-2):55–64.
100.
TsujiiTAttardiBWintersSJ. Regulation of alpha-subunit mRNA transcripts by pituitary adenylate cyclase-activating polypeptide (PACAP) in pituitary cell cultures and alpha T3-1 cells. Mol Cell Endocrinol. 1995;113(2):123–130.
101.
BurrinJMAylwinSJHoldstockJGSahyeU. Mechanism of action of pituitary adenylate cyclase-activating polypeptide on human glycoprotein hormone alpha-subunit transcription in alphaT3-1 gonadotropes. Endocrinology. 1998;139(4):1731–1737.
102.
GarrelGLozachABachirLKLaverriereJNCounisR. Pituitary adenylate cyclase-activating polypeptide stimulates nitric-oxide synthase type I expression and potentiates the cGMP response to gonadotropin-releasing hormone of rat pituitary gonadotrophs. J Biol Chem. 2002;277(48):46391–46401.
103.
HortonCDHalvorsonLM. The cAMP signaling system regulates LHbeta gene expression: roles of early growth response protein-1, SP1 and steroidogenic factor-1. J Mol Endocrinol. 2004;32(1):291–306.
104.
FowkesRCKingPBurrinJM. Regulation of human glycoprotein hormone alpha-subunit gene transcription in LbetaT2 gonadotropes by protein kinase C and extracellular signal-regulated kinase 1/2. Biol Reprod. 2002;67(3):725–734.
105.
AttardiBWintersSJ. Transcriptional regulation of the glycoprotein hormone alpha-subunit gene by pituitary adenylate cyclase-activating polypeptide (PACAP) in alphaT3-1 cells. Mol Cell Endocrinol. 1998;137(2):97–107.
PurwanaINKanasakiHOrideAMijiddorjTMiyazakiK. Expression of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) potentiates the effects of GnRH on gonadotropin subunit gene expression. Biochem Biophys Res Commun. 2011;410(2):295–300.
108.
NganESLeungPCChowBK. Interplay of pituitary adenylate cyclase-activating polypeptide with a silencer element to regulate the upstream promoter of the human gonadotropin-releasing hormone receptor gene. Mol Cell Endocrinol. 2001;176(1-2):135–144.
109.
LariviereSGarrel-LazayresGSimonVGonadotropin-releasing hormone inhibits pituitary adenylyl cyclase-activating polypeptide coupling to 3′,5′-cyclic adenosine-5'-monophosphate pathway in LbetaT2 gonadotrope cells through novel protein kinase C isoforms and phosphorylation of pituitary adenylyl cyclase-activating polypeptide type I receptor. Endocrinology. 2008;149(12):6389–6398.
110.
McArdleCAPochASchomerusEKratzmeierM. Pituitary adenylate cyclase-activating polypeptide effects in pituitary cells: modulation by gonadotropin-releasing hormone in alpha T3-1 cells. Endocrinology. 1994;134(6):2599–2605.
111.
MooreJP Jr, VillafuerteBCUnickCAWintersSJ. Developmental changes in pituitary adenylate cyclase activating polypeptide expression during the perinatal period: possible role in fetal gonadotroph regulation. Endocrinology. 2009;150(10):4802–4809.
112.
MooreJP Jr, WilsonLDalkinACWintersSJ. Differential expression of the pituitary gonadotropin subunit genes during male rat sexual maturation: reciprocal relationship between hypothalamic pituitary adenylate cyclase-activating polypeptide and follicle-stimulating hormone beta expression. Biol Reprod. 2003;69(1):234–241.
113.
MooreJP Jr, YangRQWintersSJ. Targeted pituitary overexpression of pituitary adenylate-cyclase activating polypeptide alters postnatal sexual maturation in male mice. Endocrinology. 2012;153(3):1421–1434.
114.
ShiodaSLegradiGLeungWCNakajoSNakayaKArimuraA. Localization of pituitary adenylate cyclase-activating polypeptide and its messenger ribonucleic acid in the rat testis by light and electron microscopic immunocytochemistry and in situ hybridization. Endocrinology. 1994;135(3):818–825.
115.
OgiKKimuraCOndaHArimuraAFujinoM. Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun. 1990;173(3):1271–1279.
116.
DanielPBHabenerJF. Pituitary adenylate cyclase-activating polypeptide gene expression regulated by a testis-specific promoter in germ cells during spermatogenesis. Endocrinology. 2000;141(3):1218–1227.
117.
HarakallSABrandenburgCAGilmartinGAMayVBraasKM. Induction of multiple pituitary adenylate cyclase activating polypeptide (PACAP) transcripts through alternative cleavage and polyadenylation of proPACAP precursor mRNA. Ann N Y Acad Sci. 1998;865:367–374.
118.
BanksWAKastinAJKomakiGArimuraA. Pituitary adenylate cyclase activating polypeptide (PACAP) can cross the vascular component of the blood-testis barrier in the mouse. J Androl. 1993;14(3):170–173.
119.
KononenJPaavolaMPenttilaTLParvinenMPelto-HuikkoM. Stage-specific expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in the rat seminiferous tubules. Endocrinology. 1994;135(5):2291–2294.
120.
YanaiharaHVighSKoziczTSomogyvari-VighAArimuraA. Immunohistochemical demonstration of the intracellular localization of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat testis using the stamp preparation. Regul Pept. 1998;78(1-3):83–88.
121.
HannibalJFahrenkrugJ. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells. Regul Pept. 1995;55(1):111–115.
122.
HeindelJJPowellCJPaschallCSArimuraACullerMD. A novel hypothalamic peptide, pituitary adenylate cyclase activating peptide, modulates Sertoli cell function in vitro. Biol Reprod. 1992;47(5):800–806.
123.
DanielPBKiefferTJLeechCAHabenerJF. Novel alternatively spliced exon in the extracellular ligand-binding domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) selectively increases ligand affinity and alters signal transduction coupling during spermatogenesis. J Biol Chem. 2001;276(16):12938–12944.
124.
LiMFunahashiHMbikayMShiodaSArimuraA. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells. Endocrine. 2004;23(1):59–75.
125.
MontsBSBreyerPRRothrockJKPescovitzOH. Peptides of the growth hormone-releasing hormone family: differential expression in rat testis. Endocrine. 1996;4(1):73–78.
126.
KrempelsKUsdinTBHartaGMezeyE. PACAP acts through VIP type 2 receptors in the rat testis. Neuropeptides. 1995;29(6):315–320.
127.
MatsumotoSArakawaYOhishiMYanaiharaHIwanagaTKurokawaN. Suppressive action of pituitary adenylate cyclase activating polypeptide (PACAP) on proliferation of immature mouse Leydig cell line TM3 cells. Biomed Res. 2008;29(6):321–330.
128.
WestAPMcKinnellCSharpeRMSaundersPT. Pituitary adenylate cyclase activating polypeptide can regulate testicular germ cell protein synthesis in vitro. J Endocrinol. 1995;144(2):215–223.
129.
RomanelliFFilloSIsidoriAConteD. Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro. Neuropeptides. 1997;31(4):311–317.
130.
El-GehaniFTena-SempereMHuhtaniemiI. Evidence that pituitary adenylate cyclase-activating polypeptide is a potent regulator of fetal rat testicular steroidogenesis. Biol Reprod. 2000;63(5):1482–1489.
131.
CsabaZCsernusVGerendaiI. Local effect of PACAP and VIP on testicular function in immature and adult rats. Peptides. 1997;18(10):1561–1567.
132.
LissbrantECollinOBerghA. Pituitary adenylate cyclase-activating polypeptide (PACAP): effects on blood flow in the testis and caput epididymidis of the rat. J Androl. 1999;20(3):366–374.
133.
LacombeALelievreVRoselliCEDelayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice. Proc Natl Acad Sci U S A. 2006;103(10):3793–3798.
134.
LiMMbikayMArimuraA. Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology. 2000;141(10):3723–3730.
135.
ShiodaSNakaiYNakajoSNakayaKArimuraA. Localization of pituitary adenylate cyclase-activating polypeptide and its type I receptors in the rat ovary: immunohistochemistry and in situ hybridization. Ann N Y Acad Sci. 1996;805:677–683.
136.
KoCInYHPark-SargeOK.Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology. 1999;140(11):5185–5194.
137.
ScaldaferriLAroraKLeeSHCattKJMorettiC. Expression of PACAP and its type-I receptor isoforms in the rat ovary. Mol Cell Endocrinol. 1996;117(2):227–232.
138.
KotaniEUsukiSKuboT. Rat corpus luteum expresses both PACAP and PACAP type IA receptor mRNAs. Peptides. 1997;18(9):1453–1455.
139.
GrasSHedetoftCPedersenSHFahrenkrugJ. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes. Biol Reprod. 2000;63(1):206–212.
140.
CecconiSRossiGBarberiMScaldaferriLCanipariR. Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro. Endocrinology. 2004;145(4):2071–2079.
141.
PesceMCanipariRFerriGLSiracusaGDe FeliciM. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylate cyclase and promotes proliferation of mouse primordial germ cells. Development. 1996;122(1):215–221.
142.
VaccariSLatiniSBarberiMTetiAStefaniniMCanipariR. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. J Endocrinol. 2006;191(1):287–299.
143.
HeindelJJSneedenJPowellCJDavisBCullerMD. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro. Biol Reprod. 1996;54(3):523–530.
144.
GrasSHannibalJFahrenkrugJ. Pituitary adenylate cyclase-activating polypeptide is an auto/paracrine stimulator of acute progesterone accumulation and subsequent luteinization in cultured periovulatory granulosa/lutein cells. Endocrinology. 1999;140(5):2199–2205.
145.
GrasSHostEFahrenkrugJ. Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary. Regul Pept. 2005;128(1):69–74.
146.
ApaRLanzoneAMastrandreaMEffect of pituitary adenylate cyclase-activating peptide on meiotic maturation in follicle-enclosed, cumulus-enclosed, and denuded rat oocytes. Biol Reprod. 1997;57(5):1074–1079.
147.
TengCHKeFCLeeMTLinSWChenLHwangJJ. Pituitary adenylate cyclase-activating polypeptide acts synergistically with relaxin in modulating ovarian cell function in rats. J Endocrinol. 2000;167(1):61–69.
148.
ApaRLanzoneAMiceliFPituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell. Biol Reprod. 2002;66(3):830–835.
149.
JamenFRodriguez-HencheNPralongFPAC1 null females display decreased fertility. Ann N Y Acad Sci. 2000;921:400–404.
150.
IsaacERSherwoodNM. Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice. Mol Cell Endocrinol. 2008;280(1-2):13–19.
151.
SherwoodNMAdamsBAIsaacERWuSFradingerEA. Knocked down and out: PACAP in development, reproduction and feeding. Peptides. 2007;28(9):1680–1687.
152.
ShintaniNMoriWHashimotoHDefects in reproductive functions in PACAP-deficient female mice. Regul Pept. 2002;109(1-3):45–48.
JamenFPerssonKBertrandGPAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest. 2000;105(9):1307–1315.
155.
GraySLCummingsKJJirikFRSherwoodNM. Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol. 2001;15(10):1739–1747.
156.
HashimotoHShintaniNTanakaKAltered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A. 2001;98(23):13355–13360.
157.
SpencerFChiLZhuM. Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats. Comp Biochem Physiol Toxicol Pharmacol. 2001;129(1):25–34.
158.
SteenstrupBJorgensenJAlmPPituitary adenylate cyclase activating polypeptide (PACAP): occurence and vasodilatory effect in the human uteroplacental unit. Regul Pept. 1996;61(3):197–204.
159.
ScaldaferriMModestiAPalumboCPituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Endocrinology. 2000;41(3):1158–1167.
160.
KohPWonCNohHChoGChoiW. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. J Vet Sci. 2005;6(1):1–5.
161.
BorzseiRMarkLBagolyTPresence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk. Eur J Endocrinol. 2009;160(4):561–565.
